x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Talking Biotech with Dr. Kevin Folta

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

science life sciences

All Episodes

41:59

The Changing Biotech Business and Big Data Ecosystem...

Talking Biotech with Dr. Kevin Folta ·

2023/04/01

In a rapidly changing technology environment, how do established businesses tackle smart growth and continue transformative change? In this special edition of Talking Biotech Podcast we examine the business climate of Regeneron, and how growth in the era of genomics and massive data sets from human health changed the process of drug discovery, but also changed how the company would respond to new opportunities and challenges. Dr. Jeffery Reid, Chief Data Officer, explains where the company

en-us

44:58

Science Controversies in Social Media - Dr. Liza Dunn

Talking Biotech with Dr. Kevin Folta ·

2023/03/25

In this episode Dr. Kevin Folta shares a spontaneous conversation with Dr. Liza Dunn. Dr. Dunn is an emergency medicine physician with a specialty in medical toxicology, now working as the Medical Affair Lead at Bayer CropScience. The discussion covers the current scientific environment in social media, and emphasizes the need for scientists to be engaging. Topics from communication about vaccines to genetic engineering are covered. Follow Dr. Dunn at @DrLizaMD

en-us

27:56

Biotech Potatoes and Food Security - Dr. David Douches

Talking Biotech with Dr. Kevin Folta ·

2023/03/18

The potato is a world food staple, yet it is constantly threated by fungal and viral pathogens in all of its growing regions. Farmers combat these problems with chemistry, which cuts farmers profits and has potential consequences for applicators and the environment. Dr. David Douches from Michigan State University discusses the USAID project that installed a cassette of disease resistance genes from wild potato species in the cultivated potato. The result is a potato that can survive better

en-us

16:21

Students Against Misinformation -Special Episode-

Talking Biotech with Dr. Kevin Folta ·

2023/03/06

Whereas we used to be challenged with finding information, today we are flooded with information, and our job has switched to vetting it's merits. Three students from the University of Florida spoke to me about their efforts in a national competition to study the origins of false information and communicate how to identify good information to the public. Tammy, Heather and Courtney were amazing guests that discussed their mission, along with a suite of online resources to help guide the

en-us

38:06

Treating Mental Illness through Nasal Drug Delivery -...

Talking Biotech with Dr. Kevin Folta ·

2023/03/04

Mental illnesses such as anxiety and depression are being diagnosed with increasing frequency. At the same time, treatment is frequently dependent on legacy drugs that oftentimes to do not work well, have drug interactions, or can lead to addiction or dependence. New therapies are also available, yet they they are systemic and can also have drug interactions and unfavorable side effects. New therapies are needed, especially those with more direct delivery to the relevant regions of the

en-us

28:02

Reinventing Lipid Nanoparticles - Dr. John Lewis

Talking Biotech with Dr. Kevin Folta ·

2023/02/25

Lipid nanoparticles have been around for decades, but they took a spotlight in the delivery of the COVID19 mRNA-based vaccines. This chemical cage can fuse with cell membranes and deliver a specific payload to a cell. While the delivery to specific cells is routine, are there ways to improve the system to have more specific therapeutic benefit. Dr. John Lewis of Entos discusses lipid nanoparticle chemistry and new formulations that exhibit enhanced capacity to target specific locations and

en-us

36:54

Gene Therapy to Cure Rare Disease - Dr. Gaurav Shah

Talking Biotech with Dr. Kevin Folta ·

2023/02/18

There are many rare diseases that originate with a single letter change in DNA, and they can cause tremendous physical and financial hardship for families affected. Viral-based gene therapies have been a promise for decades, and modern technology is now bringing these concepts to fruition. Dr. Gaurav Shah, CEO of Rocket Pharma, describes the power of the current gene therapy approaches, along with the pipeline of potential therapeutics that could represent cures for rare disease.

en-us

47:10

Inspiring Innovations; State of Alzheirmer's...

Talking Biotech with Dr. Kevin Folta ·

2023/02/11

This week's podcast has two parts. Dr. Leen Kawas , Managing General Partner at Propel Biopartners, speaks about how biotech startups can benefit from skilled oversight and capital provided from experts that understand the business/science ecosystem. In the second part we discuss the latest therapies for Alzheimer's Disease, and how trials and regulation can't follow traditional trajectories. Alzheimer's has variation in etiology, patients start treatments after a diagnosis which may be

en-us

37:23

Nature's Transgenics - Evidence of Lateral Gene...

Talking Biotech with Dr. Kevin Folta ·

2023/02/04

As the amount of plant genomic DNA sequence increases, scientists have detected DNA sequence information that simply does not conveniently fit into genome assemblies, and clearly appears to be from somewhere else. Dr. Lara Pereira from the University of Sheffield explains the surprising frequency of lateral gene transfer between grass species. The mechanism of crossing the species barrier is discussed, along with the frequency of horizontal transfer. We discuss the ramifications of

en-us

28:03

Status of the Biotech Salmon - Silvia Wulf

Talking Biotech with Dr. Kevin Folta ·

2023/01/28

Salmon are outstanding table fare, featuring flavor and nutrition. The AquAdvantage salmon is a genetically engineered salmon that is resistant to changes in growth due to seasonal fluctuation or the stresses encountered in traditional ocean-net salmon farms. Despite the advantages, the salmon has been caught in deregulation for many years, limiting consumer access. Silvia Wulf of AquAdvantage talks about the current status of availability, the technology, the criticisms and the future of

en-us

50:53

Stopping Long-Term Disease by Arresting Aging - Dr....

Talking Biotech with Dr. Kevin Folta ·

2023/01/21

The mythical Fountain of Youth may be an actual component of our physiology. Aging is not simply the body breaking down against the calendar, it is a coordinated series of molecular/biochemical changes that occur with time. There is an active hypothesis that later-life medical issues are not just happening as we age, but are actually caused by aging, meaning there are potential drug targets that may slow the process. BioAge performed -omics level analysis on populations of aging

en-us

58:21

The Risks of Manufactured Viruses - Dr. Kevin Esvelt

Talking Biotech with Dr. Kevin Folta ·

2023/01/14

What are the risks associated with being able to create custom DNA? Today's podcast discusses the potential weaponization of synthesized nucleic acid sequences. Dr. Kevin Esvelt discusses synthetic DNA and synthetic viruses, along with the possibility that they may drive the next pandemics or become the basis for future biological weapons. The dark realities are discussed, along with surveillance and mitigation strategies, as well as the broken social trust that could fuel a human-made

en-us

41:21

Biotech Fetal Diagnostics - Daniel Weisman

Talking Biotech with Dr. Kevin Folta ·

2023/01/07

If a genetic disorder can be detected in the developing fetus, it provides families and physicians vital information that can guide important decisions. From family planning to medical intervention, new molecular techniques are being employed to detect potential anomalies as early as 10 weeks after conception. The modern genetic counselor is an expert at communicating the results of these tests, building trust to advise decisions that benefit the parents and the child.

en-us

36:08

Brexit May Bring Gene Editing to the UK- Cameron...

Talking Biotech with Dr. Kevin Folta ·

2022/12/31

While there are many views on Brexit, one certain benefit is the UK's self-governing role in scientific regulatory affairs. The EU's position on genetic engineering has perplexed its scientists, as they create solutions for EU farmers that may never be implemented. Now out from the EU's onerous non-scientific regulatory oversight, the UK may choose to deregulate gene editing. Cameron English talks about the proposed regulatory changes and how they may benefit the UK's farmers and

en-us

36:41

Releasing the Biotech Blight Resistant Chestnut -...

Talking Biotech with Dr. Kevin Folta ·

2022/12/24

The American chestnut was a dominant tree in many forests in the eastern United States. In the late 1800's an imported fungus spread rapidly throughout the range, destroying most of the trees in a matter of decades. Scientists at the State University of New York have engineered trees to host a gene from wheat that disarms the fungal invader, breaking the production of an acid required for infection. This strategy allows the tree and the fungus to live together without infection. Erik

en-us

36:23

New Cancer Drugs: Breaking the Cell Cycle -- Spiro...

Talking Biotech with Dr. Kevin Folta ·

2022/12/17

The "cell cycle" describes discrete steps in the process of cell division. The progression is mediated by a series of gatekeeping biochemical activities that ensure complete replication of DNA, and surveil it for fidelity. Precise execution of cell cycle is necessary for normal growth and development. At the same time, loss of cell cycle coordination can lead to aberrant cell proliferation that can become genetically unstable, a condition recognized as cancer. Many drugs target the

en-us

54:08

Bioengineering Yeast for Better Beer - Dr. Charles Denby

Talking Biotech with Dr. Kevin Folta ·

2022/12/10

Beer is a beverage derived from the fermentation of grain by yeast. Hops impart their specific flavor and aroma notes. Together these ingredients produce a vast array of flavors and aromas that have become extremely popular in modern beer circles. Like any industrial workhorse organism, brewing yeast is significantly different from its wild antecedents. It has been bred to perform in fermentation, while creating metabolites that touch the senses of the consumer. Berkeley Yeast is taking

en-us

20:11

Genes Controlling Plant Size

Talking Biotech with Dr. Kevin Folta ·

2022/12/03

Bigger plants are better, right? Not always. Control of plant or tree size can have many advantages, and genetic control of 'dwarf' phenotypes has been important in feeding a billion people. The problem is that the changes induced by dwarfing genes can have a negative effect on other aspects of plant biology, so identifying new genes to control size is an important goal. Dr. Philippa Borrill is a group leader at the John Innes Center, and she recently discovered a gene that contributes to

en-us

65:59

As Gods: A Moral History of the Genetic Age - Matthew...

Talking Biotech with Dr. Kevin Folta ·

2022/11/26

The modern era of genetic engineering has opened tremendous opportunities in medicine and agriculture. But who governs when the technology should be applied? Similar questions were asked in the 1970s at the dawn of recombinant DNA technology. In his new book As Gods - A Moral History of the Genetic Age, Prof. Matthew Cobb discusses these watershed moments in molecular biology, and discusses his views on the newest applications in gene drives, human germline gene editing, and

en-us

41:18

The Genomes of Parasites - Dr. Jessie Kissinger

Talking Biotech with Dr. Kevin Folta ·

2022/11/19

Parasites are known contributors to human disease and suffering, spanning a wide range of organisms. Dr. Jessie Kissinger from the University of Georgia has spent the last two decades curating genomic data from hundreds of parasites, their vectors and hosts. The information helps researchers generate hypotheses about parasites, and presents a fertile resources for comparing genomes and understanding similarities and differences across this diverse set of organisms. VEuPathDB.org (Vector

en-us

486 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter